Share of the population living with HIV receiving antiretroviral therapy in Nigeria

Nigeria: Share of the population living with HIV receiving antiretroviral therapy was 83.3% in 2024. ◆ Volatile

Latest (2024)
83.3%
Change on year
up 8.3%
World rank
44th
of 149 countries
All-time high
83.3%
in 2024
All-time low
0.0%
in 1990
Years of data
35
1990–2024

Share of the population living with HIV receiving antiretroviral therapy in Nigeria, 1990–2024

0204060801990200720241990: 0 %1991: 0 %1992: 0 %1993: 0 %1994: 0 %1995: 0 %1996: 0 %1997: 0 %1998: 0 %1999: 0 %2000: 0.117 %2001: 0.226 %2002: 0.735 %2003: 0.998 %2004: 2.5 %2005: 3.4 %2006: 6.5 %2007: 7.1 %2008: 12.2 %2009: 15.9 %2010: 17.5 %2011: 20 %2012: 25.6 %2013: 30.9 %2014: 34.8 %2015: 38.4 %2016: 43.4 %2017: 46.3 %2018: 46.7 %2019: 52.6 %2020: 58.5 %2021: 64.5 %2022: 70.7 %2023: 76.9 %2024: 83.3 %

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.

Analysis

In 2024, share of the population living with hiv receiving antiretroviral therapy in Nigeria stood at 83.3%. That is the highest value across all 35 years on record.

That represents a change of up 8.3% on the previous year and up 139.3% over ten years.

Over the whole period, share of the population living with hiv receiving antiretroviral therapy in Nigeria peaked at 83.3% in 2024 and was at its lowest, 0.0%, in 1990.

That places Nigeria 44th out of 149 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Share of the population living with HIV receiving antiretroviral therapy in Nigeria, year by year

Annual values for Share of the population living with HIV receiving antiretroviral therapy in Nigeria, 1990 to 2024.
Year % Change
1990 0.0% —
1991 0.0% —
1992 0.0% —
1993 0.0% —
1994 0.0% —
1995 0.0% —
1996 0.0% —
1997 0.0% —
1998 0.0% —
1999 0.0% —
2000 0.1% —
2001 0.2% +93.5%
2002 0.7% +225.0%
2003 1.0% +35.8%
2004 2.5% +148.6%
2005 3.4% +37.6%
2006 6.5% +91.2%
2007 7.1% +9.2%
2008 12.2% +71.3%
2009 15.9% +29.9%
2010 17.5% +10.5%
2011 20.0% +14.1%
2012 25.6% +27.9%
2013 30.9% +20.7%
2014 34.8% +12.8%
2015 38.4% +10.4%
2016 43.4% +12.8%
2017 46.3% +6.8%
2018 46.7% +0.9%
2019 52.6% +12.6%
2020 58.5% +11.3%
2021 64.5% +10.2%
2022 70.7% +9.5%
2023 76.9% +8.7%
2024 83.3% +8.3%

Nigeria compared with similar countries

  • Nigeria's 83.3% is above the median for lower middle income countries, which is 76.0%, 1.1× the median. (40 countries reporting)
  • Nigeria's 83.3% is above the median for Sub-Saharan Africa, which is 81.2%, 1.0× the median. (44 countries reporting)

Biggest year-on-year movements

Years where Share of the population living with HIV receiving antiretroviral therapy in Nigeria changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2002 +225.0% 0.2% 0.7%
2004 +148.6% 1.0% 2.5%
2001 +93.5% 0.1% 0.2%
2006 +91.2% 3.4% 6.5%
2008 +71.3% 7.1% 12.2%

Averages by decade

DecadeAverage LowestHighest Years
1990s 0.0% 0.0% 0.0% 10
2000s 5.0% 0.1% 15.9% 10
2010s 35.6% 17.5% 52.6% 10
2020s 70.8% 58.5% 83.3% 5

Countries ranked near Nigeria

  1. 41 New Zealand 84.2% compare
  2. 42 Comoros 84.1% compare
  3. 43 Luxembourg 83.8% compare
  4. 45 Ecuador 82.1% compare
  5. 46 Burkina Faso 82.0% compare
  6. 47 Portugal 82.0% compare

See the full ranking of 149 places →

More reference data data for Nigeria

All data for Nigeria →

Frequently asked questions

What is share of the population living with hiv receiving antiretroviral therapy in Nigeria?
Share of the population living with hiv receiving antiretroviral therapy in Nigeria was 83.3% in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in Nigeria?
The highest recorded value was 83.3% in 2024.
What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in Nigeria?
The lowest recorded value was 0.0% in 1990.
How does Nigeria rank for share of the population living with hiv receiving antiretroviral therapy?
Nigeria ranks 44th out of 149 countries with data for 2024.
Is share of the population living with hiv receiving antiretroviral therapy rising or falling in Nigeria?
Over the last ten years it is up 139.3%. The long-run trend across the full record is volatile.
Where does this Nigeria data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of the population living with HIV receiving antiretroviral therapy in Nigeria. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Retrieved 29 September 2026, from https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/nigeria/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/nigeria/">Share of the population living with HIV receiving antiretroviral therapy in Nigeria</a> — Statizoid

About this data

Indicator
Share of the population living with HIV receiving antiretroviral therapy
Unit
%
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
149 places, 5,062 data points, 1990–2024
Last refreshed

Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.